Ajax-Loading

Merck & Company Inc - Net Income

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Net-Income" stands at 19.03 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Merck & Company Inc's third quarter result of 5.78 Billion USD for the item "Net Income" represents an increase of 30.68 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 5.78 Billion USD for the item "Net Income" represents an increase of 83.24 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 19.03 Billion USD for the item "Net Income" represents an increase of 16.02 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 56.68 percent compared to the value the year prior.
The 1 year change in percent is 56.68.
The 3 year change in percent is 24.73.
The 5 year change in percent is 65.25.
The 10 year change in percent is 76.53.

The Serie's long term average value is 8.07 Billion United States Dollars. It's latest available value, on 09/30/2025, is 135.92 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +5,114.79%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Net Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Income905,699,262,464.00
LogoJohnson & Johnson - Net Income486,508,953,600.00
LogoAbbVie Inc - Net Income399,570,305,024.00
LogoRoche Holding AG - Net Income317,433,206,677.55
LogoAstraZeneca PLC - Net Income280,205,508,085.11